Kimberly-Clark Completes Kenvue Acquisition

The deal creates a global consumer health and wellness company spanning baby care, women's health, and active aging brands.

Updated on Nov. 2, 2026 in Healthcare

Bold vector editorial illustration of two clusters of plain unlabeled cartons and bottles on a pale surface, one cluster merging into the other, in coral, teal, and mustard. — Kimberly-Clark completed its $48.7 billion acquisition of Kenvue on November 2, forming a consumer health company targeting about $2.1 billion in run-rate synergies. AI Illustration. Upload story photo >

Live Poll

Do you trust big consumer brand mergers to benefit everyday shoppers?

Kimberly-Clark Corp. completed its acquisition of Kenvue on November 2, 2026, forming a combined company that manages a portfolio including 10 billion-dollar brands. The company reaffirmed run-rate synergies of approximately $2.1 billion.

Why it matters

The combination brings together brands such as Huggies, Tylenol, Listerine, and Kleenex under one company, expanding its reach across consumer health and personal care categories. The synergy targets indicate the company's plan to pair cost reductions with revenue growth from the merged portfolio.

Kimberly-Clark reaffirmed run-rate synergies of approximately $2.1 billion, including about $1.9 billion in cost synergies over the first three years and about $500 million in incremental revenue-synergy profit within four years, net of roughly $300 million in reinvestment. North America generates about $18 billion in annual sales, while Asia Pacific Focus Markets generates about $4.3 billion.

The players

Kimberly-Clark Corp.

A Dallas-based consumer products company founded 154 years ago that markets household and personal care brands worldwide.

Kenvue

A consumer health company whose brands include Tylenol, Listerine, Neutrogena, and Johnson's Baby, now combined with Kimberly-Clark.

The details

Kimberly-Clark said the combined company intends to elevate the standard of care through three strategic pillars: better care, more hands, and smarter health. The company said it has substantially built its pipeline of cost and revenue initiatives and will move with speed and purpose to unlock the full potential of the combination.

November 2, 2026: Kimberly-Clark completed its acquisition of Kenvue.
Over the first three years after close: Kimberly-Clark expects to capture approximately $1.9 billion in cost synergies.
Within four years post-close: Kimberly-Clark expects to capture approximately $500 million in revenue-synergy profit.

Market Landscape

The completed Kenvue acquisition places Kimberly-Clark among the largest consumer health and personal care companies, combining Huggies and Kleenex with Tylenol and Listerine. It extends a broader pattern of consumer goods companies consolidating health-adjacent brands to compete in categories such as baby care and women's health.

Shoppers may see Kimberly-Clark and Kenvue brands such as Tylenol, Huggies, and Listerine sold under a single corporate parent, though the stub does not state any changes to pricing or product availability. Consumers buying these products should watch for packaging or retail changes as the integration proceeds.

The takeaway

Consolidation in consumer health is increasingly about pairing cost cuts with revenue growth from established brands. Watching whether the synergy targets are met over the next four years will show whether the strategy delivers.